CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Pittsburgh, Pennsylvania, United States and 19 other locations
This research study is studying a drug combination of nivolumab and ipilimumab as a possible treatment for hypermutated HER2 negative breast ...
Phase 2
Pittsburgh, Pennsylvania, United States and 2 other locations
This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...
Phase 2
Pittsburgh, Pennsylvania, United States and 4 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Pittsburgh, Pennsylvania, United States and 32 other locations
The purpose of this study is to determine how well participants with stage II-III HER2-positive breast cancer respond to pre-operat...
Phase 2
Pittsburgh, Pennsylvania, United States and 13 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Pittsburgh, Pennsylvania, United States and 226 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Pittsburgh, Pennsylvania, United States and 61 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Pittsburgh, Pennsylvania, United States and 50 other locations
Newly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer are eligible to a randomized trial, concur...
Phase 2
Pittsburgh, Pennsylvania, United States and 7 other locations
works in treating patients with HER2 positive or triple negative breast cancer when image-guided biopsy shows no residual cancer...
Pittsburgh, Pennsylvania, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal